1
|
Arbuthnot EJ, Parker J, Cecil T, Mohamed F, Williams R, Page M, Moran B. Peritoneal malignancy in the global COVID-19 pandemic: experience of recovery and restoration in a high-volume centre through NHS and independent sector collaboration. Ann R Coll Surg Engl 2024; 106:385-388. [PMID: 38038177 PMCID: PMC10981979 DOI: 10.1308/rcsann.2022.0074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/16/2022] [Indexed: 12/02/2023] Open
Abstract
INTRODUCTION Treatment of peritoneal malignancy with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) requires substantial critical care, theatre and nursing resources. The COVID-19 pandemic caused challenges in providing a high volume, tertiary referral service. METHODS We reviewed data on referrals and operations performed in a tertiary referral centre in both NHS and independent sector settings. The impact of COVID-19 on activity was assessed using 2019 as a benchmark. RESULTS New patient referrals were similar, with 891 in 2019 compared with 833 in 2020. Delivery of CRS and HIPEC operations were initially impacted by COVID-19. NHS and independent sector collaboration facilitated recovery, with 284 patients treated in 2020 compared with 280 in 2019. CONCLUSIONS Close collaboration and structural organisation between the clinical and management teams in the NHS and independent sectors facilitated recovery and restoration of a complex tertiary referral service for peritoneal malignancy during the COVID pandemic.
Collapse
Affiliation(s)
- EJ Arbuthnot
- Peritoneal Malignancy Institute, Hampshire Hospitals NHS Foundation Trust, UK
| | - J Parker
- Peritoneal Malignancy Institute, Hampshire Hospitals NHS Foundation Trust, UK
| | | | | | - R Williams
- Peritoneal Malignancy Institute, Hampshire Hospitals NHS Foundation Trust, UK
| | | | | |
Collapse
|
2
|
Ma Y, Mason EM, McGinn EM, Parker J, Oxley JD, St Louis KO. Attitudes toward stuttering of college students in the USA and China: A cross-cultural comparison using the POSHA-S. J Fluency Disord 2024; 79:106037. [PMID: 38301423 DOI: 10.1016/j.jfludis.2024.106037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/12/2023] [Revised: 12/19/2023] [Accepted: 01/09/2024] [Indexed: 02/03/2024]
Abstract
PURPOSE This study compared the attitudes toward stuttering among college students in China and the USA using the POSHA-S survey, which assesses knowledge about stuttering and attitudes toward it. We investigated how cultural and social differences between the two groups influenced these attitudes. METHODS We collected 199 responses to the POSHA-S survey from various universities in China and the USA. We conducted a statistical analysis of 15 summary scores generated from the POSHA-S to determine if there were significant differences in attitudes toward stuttering between the two groups. Additionally, we retrieved percentile ranks relative to the global POSHA-S database to compare attitudes in both groups with global median scores. RESULTS The study revealed that Chinese college students hold more negative attitudes toward stuttering compared to their American counterparts and the global median scores. We discussed the social and cultural factors that may contribute to these attitudes. Furthermore, our findings emphasized the importance of addressing the lack of accurate information about stuttering in China, which could be a key factor driving these negative attitudes. CONCLUSION These results underscore the urgent need to raise awareness about stuttering and promote a shift in public attitudes, especially among college students in China, who play influential roles in society's future.
Collapse
Affiliation(s)
- Yan Ma
- Department of Communication Sciences and Disorders, Purdue University Fort Wayne, 2101 East Coliseum Boulevard, CLCB 113, Fort Wayne, IN 46805, United States.
| | - Emmalee M Mason
- Prosser Memorial Hospital, 326 Chardonnay Ave., Prosser, WA 99350, United States
| | - Evynn M McGinn
- Signature Home Health, 454 NE Revere Ave, Bend, OR 97701, United States
| | - Jordan Parker
- Department of Communication Sciences & Disorders, Fort Hays State University, 600 Park St., Hays, KS 67601, United States
| | - Judith D Oxley
- Department of Communicative Disorders, University of Louisiana at Lafayette, P.O. Box 43170 Lafayette, LA 70504, United States
| | - Kenneth O St Louis
- Department of Communication Sciences & Disorders, West Virginia University, P.O. Box 4382, Morgantown, WV 26506, United States
| |
Collapse
|
3
|
Partridge E, Adam E, Wood C, Parker J, Johnson M, Horohov D, Page A. Residual effects of intra-articular betamethasone and triamcinolone acetonide in an equine acute synovitis model. Equine Vet J 2023; 55:905-915. [PMID: 36397207 DOI: 10.1111/evj.13899] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2022] [Accepted: 11/10/2022] [Indexed: 11/19/2022]
Abstract
BACKGROUND Intra-articular (IA) corticosteroids are regularly used in equine athletes for the control of joint inflammation. OBJECTIVES The goal of this study was to use an acute synovitis inflammation model to determine the residual effects of IA betamethasone and triamcinolone acetonide on various inflammatory parameters and lameness. STUDY DESIGN Crossover randomised trial. METHODS Five mixed-breed, 2-year-old horses were randomly allocated to an IA treatment of the radiocarpal joint with 9 mg of either betamethasone or triamcinolone acetonide. Two weeks following treatment, horses were injected with 1 μg of lipopolysaccharide (LPS) diluted in 1 ml of saline. Following LPS injection, horses were crossed-over and both sets of injections were repeated after a washout period. Blood samples were collected at multiple time points for mRNA analysis, as well as serum amyloid A (SAA) and cortisol determination. At each time point, lameness was also subjectively scored. Additional injections with saline-only or LPS-only (twice) were conducted as negative and positive controls, respectively. Two-way repeated measures analysis of variance was used to analyse all data. RESULTS Corticosteroid-only treatments result in significant mRNA expression differences, as well as significant and prolonged cortisol suppression. Following LPS injection, there was a residual treatment effect with triamcinolone evidenced by a significant treatment effect on IL-6 and PTGS1 (cyclooxygenase-1), lameness, SAA and cortisol concentrations, while only IL-6 expression was affected by betamethasone. MAIN LIMITATIONS The acute synovitis model used here results in significant inflammation and is not representative of the low-grade inflammation seen with typical joint disease and residual anti-inflammatory effects may be more profound in naturally occurring joint disease. CONCLUSIONS Current regulatory guidelines may be insufficient if the concern is residual anti-inflammatory effects. Additionally, intra-articular corticosteroid administration is not without risk, as evidenced by a significant suppression of serum cortisol concentration and, as such, the benefits of their administration should be weighed against those risks.
Collapse
Affiliation(s)
- Emma Partridge
- Department of Veterinary Science, University of Kentucky, Maxwell H. Gluck Equine Research Center, Lexington, Kentucky, USA
| | - Emma Adam
- Department of Veterinary Science, University of Kentucky, Maxwell H. Gluck Equine Research Center, Lexington, Kentucky, USA
| | - Courtney Wood
- Lincoln Memorial University, Harrogate, Tennessee, USA
| | - Jordan Parker
- Department of Veterinary Science, University of Kentucky, Maxwell H. Gluck Equine Research Center, Lexington, Kentucky, USA
| | - Mackenzie Johnson
- Department of Veterinary Science, University of Kentucky, Maxwell H. Gluck Equine Research Center, Lexington, Kentucky, USA
| | - David Horohov
- Department of Veterinary Science, University of Kentucky, Maxwell H. Gluck Equine Research Center, Lexington, Kentucky, USA
| | - Allen Page
- Department of Veterinary Science, University of Kentucky, Maxwell H. Gluck Equine Research Center, Lexington, Kentucky, USA
| |
Collapse
|
4
|
Parker J, Young P, Hodson N, Shelton CL. Green nudges for sustainable anaesthetic practice: institutional support to make individual change easier. Anaesthesia 2023. [PMID: 36860116 DOI: 10.1111/anae.15991] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/07/2023] [Indexed: 03/03/2023]
Affiliation(s)
- J Parker
- Faculty of Health and Medicine, Lancaster Medical School, Lancaster University, Lancaster, UK
| | - P Young
- North West School of Anaesthesia, Health Education England North West, Manchester, UK
| | - N Hodson
- Unit of Mental Health and Wellbeing, University of Warwick, Coventry, UK
| | - C L Shelton
- Faculty of Health and Medicine, Lancaster Medical School, Lancaster University, Lancaster, UK.,Department of Anaesthesia, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK
| |
Collapse
|
5
|
Parker J, Gupta S, Shenbagaraj L, Harborne P, Ramaraj R, Karandikar S, Mottershead M, Barbour J, Mohammed N, Lockett M, Lyons A, Vega R, Torkington J, Dolwani S. Outcomes of complex colorectal polyps managed by multi-disciplinary team strategies-a multi-centre observational study. Int J Colorectal Dis 2023; 38:28. [PMID: 36735059 PMCID: PMC9898359 DOI: 10.1007/s00384-022-04299-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 11/28/2022] [Indexed: 02/04/2023]
Abstract
PURPOSE Team management strategies for complex colorectal polyps are recommended by professional guidelines. Multi-disciplinary meetings are used across the UK with limited information regarding their impact. The aim of this multi-centre observational study was to assess procedures and outcomes of patients managed using these approaches. METHOD This was a retrospective, observational study of patients managed by six UK sites. Information was collected regarding procedures and outcomes including length of stay, adverse events, readmissions and cancers. RESULTS Two thousand one hundred ninety-two complex polyps in 2109 patients were analysed with increasing referrals annually. Most presented symptomatically and the mean polyp size was 32.1 mm. Primary interventions included endoscopic therapy (75.6%), conservative management (8.3%), colonic resection (8.1%), trans-anal surgery (6.8%) or combined procedures (1.1%). The number of primary colonic resections decreased over the study period without a reciprocal increase in secondary procedures or recurrence. Secondary procedures were required in 7.8%. The median length of stay for endoscopic procedures was 0 days with 77.5% completed as day cases. Median length of stay was 5 days for colonic resections. Overall adverse event and 30-day readmission rates were 9.0% and 3.3% respectively. Malignancy was identified in 8.8%. Benign polyp recurrence occurred in 13.1% with a median follow up of 30.4 months. Screening detected lesions were more likely to undergo bowel resection. Colonic resection was associated with longer stays, higher adverse events and more cancers on final histology. CONCLUSION Multi-disciplinary team management of complex polyps is safe and effective. Standardisation of organisation and quality monitoring is needed to continue positive effects on outcomes and services.
Collapse
Affiliation(s)
- J. Parker
- School of Medicine and Cardiff and Vale University Health Board, Cardiff University, Cardiff, UK
| | - S. Gupta
- Guy’s and St. Thomas’ NHS Foundation Trust, London, UK
| | | | - P. Harborne
- Cardiff and Vale University Health Board, Cardiff, UK
| | - R. Ramaraj
- Cardiff and Vale University Health Board, Cardiff, UK
| | - S. Karandikar
- University Hospitals Birmingham Foundation NHS Trust, Birmingham, UK
| | - M. Mottershead
- University Hospitals Birmingham Foundation NHS Trust, Birmingham, UK
| | - J. Barbour
- Gateshead Health NHS Foundation Trust, Gateshead, UK
| | - N. Mohammed
- Leeds Teaching Hospitals NHS Trust and University of Leeds, Leeds, UK
| | | | - A. Lyons
- North Bristol NHS Trust, Bristol, UK
| | - R. Vega
- University College London Hospitals NHS Foundation Trust, London, UK
| | - J. Torkington
- Cardiff and Vale University Health Board, Cardiff, UK
| | - S. Dolwani
- School of Medicine and Cardiff and Vale University Health Board, Cardiff University, Cardiff, UK
| |
Collapse
|
6
|
Burgos S, Jefferys S, Peterson J, Parker J, Manickam A, Simon J, Margolis D, Browne E. PP 3.11 – 00171 The chromatin insulator CTCF inhibits HIV gene expression. J Virus Erad 2022. [DOI: 10.1016/j.jve.2022.100191] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
|
7
|
Safabakhsh S, Sar F, Martelotto L, Haegert A, Singhera G, Hanson P, Parker J, Collins C, Rohani L, Laksman Z. PROTOCOL DEVELOPMENT FOR SINGLE-NUCLEUS RNA SEQUENCING OF HUMAN HEART TISSUE. Can J Cardiol 2022. [DOI: 10.1016/j.cjca.2022.08.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
8
|
Guarneri V, Dieci M, Griguolo G, Pare Brunet L, Marin M, Miglietta F, Bottosso M, Giorgi C, Blasco P, Castillo O, Galván P, Jares P, Puig-butille J, Vivancos A, Villagrasa Gonzalez P, Parker J, Perou C, Conte P, Prat A. 140MO HER2DX genomic test in HER2-positive/hormone receptor-positive (HER2+/HR+) breast cancer (BC) treated with neoadjuvant trastuzumab (T) and pertuzumab (P): A correlative analysis from the PerELISA trial. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.175] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
9
|
Conte P, Pare Brunet L, Brasó-Maristany F, Chic N, Martinez Saez O, Dieci M, Marin M, Guarneri V, Vivancos A, Villagrasa Gonzalez P, Parker J, Perou C, Prat A. 153P HER2DX risk-score in the context of the PREDICT online-tool: A correlative analysis of the Short-HER clinical trial in early-stage HER2-positive (HER2+) breast cancer (BC). Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
10
|
Peach A, Blaise B, Parker J, Larson R. Noninflammatory presentation of cutaneous breast cancer: a retrospective case series at a single academic institution with review of the literature. Dermatol Online J 2022; 28. [DOI: 10.5070/d328458515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2022] [Accepted: 08/23/2022] [Indexed: 11/08/2022] Open
|
11
|
Highmore CJ, Melaugh G, Morris RJ, Parker J, Direito SOL, Romero M, Soukarieh F, Robertson SN, Bamford NC. Translational challenges and opportunities in biofilm science: a BRIEF for the future. NPJ Biofilms Microbiomes 2022; 8:68. [PMID: 36038607 PMCID: PMC9424220 DOI: 10.1038/s41522-022-00327-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2021] [Accepted: 08/04/2022] [Indexed: 11/17/2022] Open
Abstract
Biofilms are increasingly recognised as a critical global issue in a multitude of industries impacting health, food and water security, marine sector, and industrial processes resulting in estimated economic cost of $5 trillion USD annually. A major barrier to the translation of biofilm science is the gap between industrial practices and academic research across the biofilms field. Therefore, there is an urgent need for biofilm research to notice and react to industrially relevant issues to achieve transferable outputs. Regulatory frameworks necessarily bridge gaps between different players, but require a clear, science-driven non-biased underpinning to successfully translate research. Here we introduce a 2-dimensional framework, termed the Biofilm Research-Industrial Engagement Framework (BRIEF) for classifying existing biofilm technologies according to their level of scientific insight, including the understanding of the underlying biofilm system, and their industrial utility accounting for current industrial practices. We evidence the BRIEF with three case studies of biofilm science across healthcare, food & agriculture, and wastewater sectors highlighting the multifaceted issues around the effective translation of biofilm research. Based on these studies, we introduce some advisory guidelines to enhance the translational impact of future research.
Collapse
Affiliation(s)
- C J Highmore
- NBIC Interdisciplinary Research Fellows, UK National Biofilms Innovation Centre (NBIC), Southampton, UK.,School of Biological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, SO17 1BJ, Southampton, UK
| | - G Melaugh
- NBIC Interdisciplinary Research Fellows, UK National Biofilms Innovation Centre (NBIC), Southampton, UK.,School of Physics and Astronomy, University of Edinburgh, Edinburgh, EH9 3FD, UK.,School of Engineering, University of Edinburgh, Edinburgh, EH9 3FD, UK
| | - R J Morris
- NBIC Interdisciplinary Research Fellows, UK National Biofilms Innovation Centre (NBIC), Southampton, UK.,School of Physics and Astronomy, University of Edinburgh, Edinburgh, EH9 3FD, UK
| | - J Parker
- NBIC Interdisciplinary Research Fellows, UK National Biofilms Innovation Centre (NBIC), Southampton, UK.,School of Biological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, SO17 1BJ, Southampton, UK
| | - S O L Direito
- NBIC Interdisciplinary Research Fellows, UK National Biofilms Innovation Centre (NBIC), Southampton, UK.,School of Physics and Astronomy, University of Edinburgh, Edinburgh, EH9 3FD, UK
| | - M Romero
- NBIC Interdisciplinary Research Fellows, UK National Biofilms Innovation Centre (NBIC), Southampton, UK.,Biodiscovery Institute, School of Life Sciences, Faculty of Health and Medical Sciences, University of Nottingham, NG7 2RD, Nottingham, UK
| | - F Soukarieh
- NBIC Interdisciplinary Research Fellows, UK National Biofilms Innovation Centre (NBIC), Southampton, UK.,Biodiscovery Institute, School of Life Sciences, Faculty of Health and Medical Sciences, University of Nottingham, NG7 2RD, Nottingham, UK
| | - S N Robertson
- NBIC Interdisciplinary Research Fellows, UK National Biofilms Innovation Centre (NBIC), Southampton, UK. .,Biodiscovery Institute, School of Life Sciences, Faculty of Health and Medical Sciences, University of Nottingham, NG7 2RD, Nottingham, UK.
| | - N C Bamford
- NBIC Interdisciplinary Research Fellows, UK National Biofilms Innovation Centre (NBIC), Southampton, UK. .,Division of Molecular Microbiology, School of Life Sciences, University of Dundee, Dundee, DD1 5EH, UK.
| |
Collapse
|
12
|
Dunning D, Ahmed S, Foulkes L, Griffin C, Griffiths K, Leung JT, Parker J, Piera Pi-Sunyer B, Sakhardande A, Bennett M, Haag C, Montero-Marin J, Packman D, Vainre M, Watson P, Kuyken W, Williams JMG, Ukoumunne OC, Blakemore SJ, Dalgleish T. The impact of mindfulness training in early adolescence on affective executive control, and on later mental health during the COVID-19 pandemic: a randomised controlled trial. Evid Based Ment Health 2022; 25:ebmental-2022-300460. [PMID: 35820991 PMCID: PMC9340025 DOI: 10.1136/ebmental-2022-300460] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/24/2022] [Accepted: 06/15/2022] [Indexed: 01/04/2023]
Abstract
BACKGROUND Previous research suggests that mindfulness training (MT) appears effective at improving mental health in young people. MT is proposed to work through improving executive control in affectively laden contexts. However, it is unclear whether MT improves such control in young people. MT appears to mitigate mental health difficulties during periods of stress, but any mitigating effects against COVID-related difficulties remain unexamined. OBJECTIVE To evaluate whether MT (intervention) versus psychoeducation (Psy-Ed; control), implemented in after-school classes: (1) Improves affective executive control; and/or (2) Mitigates negative mental health impacts from the COVID-19 pandemic. METHODS A parallel randomised controlled trial (RCT) was conducted (Registration: https://osf.io/d6y9q/; Funding: Wellcome (WT104908/Z/14/Z, WT107496/Z/15/Z)). 460 students aged 11-16 years were recruited and randomised 1:1 to either MT (N=235) or Psy-Ed (N=225) and assessed preintervention and postintervention on experimental tasks and self-report inventories of affective executive control. The RCT was then extended to evaluate protective functions of MT on mental health assessed after the first UK COVID-19 lockdown. FINDINGS Results provided no evidence that the version of MT used here improved affective executive control after training or mitigated negative consequences on mental health of the COVID-19 pandemic relative to Psy-Ed. No adverse events were reported. CONCLUSIONS There is no evidence that MT improves affective control or downstream mental health of young people during stressful periods. CLINICAL IMPLICATIONS We need to identify interventions that can enhance affective control and thereby young people's mental health.
Collapse
Affiliation(s)
- Darren Dunning
- Medical Research Council Cognition and Brain Sciences Unit, Cambridge University, Cambridge, Cambridgeshire, UK
| | - S Ahmed
- Institute of Cognitive Neuroscience, University College London, London, UK
| | - L Foulkes
- Institute of Cognitive Neuroscience, University College London, London, UK
| | - C Griffin
- Institute of Cognitive Neuroscience, University College London, London, UK
| | - K Griffiths
- Medical Research Council Cognition and Brain Sciences Unit, Cambridge University, Cambridge, Cambridgeshire, UK
| | - J T Leung
- Institute of Cognitive Neuroscience, University College London, London, UK
| | - J Parker
- Medical Research Council Cognition and Brain Sciences Unit, Cambridge University, Cambridge, Cambridgeshire, UK
| | | | - A Sakhardande
- Institute of Cognitive Neuroscience, University College London, London, UK
| | - M Bennett
- Medical Research Council Cognition and Brain Sciences Unit, Cambridge University, Cambridge, Cambridgeshire, UK
| | - C Haag
- Medical Research Council Cognition and Brain Sciences Unit, Cambridge University, Cambridge, Cambridgeshire, UK
| | - Jesus Montero-Marin
- Teaching, Research and Innovation Unit, Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Spain
- Department of Psychiatry, University of Oxford, Oxford, Oxfordshire, UK
| | - D Packman
- College of Medicine and Health, University of Exeter, Exeter, UK
| | - Maris Vainre
- Medical Research Council Cognition and Brain Sciences Unit, Cambridge University, Cambridge, Cambridgeshire, UK
| | - P Watson
- Medical Research Council Cognition and Brain Sciences Unit, Cambridge University, Cambridge, Cambridgeshire, UK
| | - Willem Kuyken
- Department of Psychiatry, University of Oxford, Oxford, Oxfordshire, UK
| | - J Mark G Williams
- Department of Psychiatry, University of Oxford, Oxford, Oxfordshire, UK
| | - Obioha C Ukoumunne
- NIHR CLAHRC South West Peninsula, University of Exeter Medical School, Exeter, UK
| | - Sarah-Jayne Blakemore
- Institute of Cognitive Neuroscience, University College London, London, UK
- Department of Psychology, University of Cambridge, Cambridge, UK
| | - Tim Dalgleish
- Medical Research Council Cognition and Brain Sciences Unit, Cambridge University, Cambridge, Cambridgeshire, UK
| |
Collapse
|
13
|
Clough A, Pitt E, Nelder C, Benson R, McDaid L, Whiteside L, Davies L, Parker J, Awofisoye T, Freear L, Berresford J, Marchant T, McPartlin A, Crockett C, Salem A, Cobben D, Eccles C. OC-0420 Considerations for the clinical implementation of MRI-guided ART for H&N and lung cancers. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02556-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
14
|
Brasó-Maristany F, Martinez Saez O, Pare Brunet L, Marín-Aguilera M, Conte P, Jares P, Guarneri V, Pascual T, Puig-Butille J, Vivancos A, Parker J, Villagrasa Gonzalez P, Tolaney S, Carey L, Perou C, Prat A. 25P Research-based HER2DX in patients with early-stage HER2-positive (HER2+) breast cancer treated in the N9831 phase III clinical trial. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.03.040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
15
|
Teles Amaro P, McDaid L, Davies L, Whiteside L, Clough A, Faivre-Finn C, Parker J, Bailey R, Benson R, Nelder C, Pitt E, Eccles C, Crockett C, Salem A, Choudhury A. PO-1877 Initial experience delivering stereotactic radiotherapy to a gluteal metastasis on a 1.5T MR Linac. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)03840-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
16
|
Davies L, Parker J, Teles Amaro P, Whiteside L, Eccles C, Bailey R, Falk S, Webb J, McHugh L. OC-0132 Identifying the priority challenges of facilitating national proton beam therapy clinical trials. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02508-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
17
|
Parker J, Sewedy T, Fossey S. On-call CT head reports: auditing accuracy rates and discrepancy feedback mechanisms. Clin Radiol 2022. [DOI: 10.1016/j.crad.2022.01.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
18
|
Amiri HES, Brain D, Sharaf O, Withnell P, McGrath M, Alloghani M, Al Awadhi M, Al Dhafri S, Al Hamadi O, Al Matroushi H, Al Shamsi Z, Al Shehhi O, Chaffin M, Deighan J, Edwards C, Ferrington N, Harter B, Holsclaw G, Kelly M, Kubitschek D, Landin B, Lillis R, Packard M, Parker J, Pilinski E, Pramman B, Reed H, Ryan S, Sanders C, Smith M, Tomso C, Wrigley R, Al Mazmi H, Al Mheiri N, Al Shamsi M, Al Tunaiji E, Badri K, Christensen P, England S, Fillingim M, Forget F, Jain S, Jakosky BM, Jones A, Lootah F, Luhmann JG, Osterloo M, Wolff M, Yousuf M. The Emirates Mars Mission. Space Sci Rev 2022; 218:4. [PMID: 35194256 PMCID: PMC8830993 DOI: 10.1007/s11214-021-00868-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 12/22/2020] [Accepted: 11/22/2021] [Indexed: 06/14/2023]
Abstract
The Emirates Mars Mission (EMM) was launched to Mars in the summer of 2020, and is the first interplanetary spacecraft mission undertaken by the United Arab Emirates (UAE). The mission has multiple programmatic and scientific objectives, including the return of scientifically useful information about Mars. Three science instruments on the mission's Hope Probe will make global remote sensing measurements of the Martian atmosphere from a large low-inclination orbit that will advance our understanding of atmospheric variability on daily and seasonal timescales, as well as vertical atmospheric transport and escape. The mission was conceived and developed rapidly starting in 2014, and had aggressive schedule and cost constraints that drove the design and implementation of a new spacecraft bus. A team of Emirati and American engineers worked across two continents to complete a fully functional and tested spacecraft and bring it to the launchpad in the middle of a global pandemic. EMM is being operated from the UAE and the United States (U.S.), and will make its data freely available.
Collapse
Affiliation(s)
- H. E. S. Amiri
- UAE Ministry of Industry and Advanced Technology, Abu Dhabi, United Arab Emirates
| | - D. Brain
- Laboratory for Atmospheric and Space Physics, University of Colorado, Boulder, USA
| | - O. Sharaf
- Mohammed Bin Rashid Space Centre, Dubai, United Arab Emirates
| | - P. Withnell
- Laboratory for Atmospheric and Space Physics, University of Colorado, Boulder, USA
| | - M. McGrath
- Laboratory for Atmospheric and Space Physics, University of Colorado, Boulder, USA
| | - M. Alloghani
- Mohammed Bin Rashid Space Centre, Dubai, United Arab Emirates
| | - M. Al Awadhi
- Mohammed Bin Rashid Space Centre, Dubai, United Arab Emirates
| | - S. Al Dhafri
- Mohammed Bin Rashid Space Centre, Dubai, United Arab Emirates
| | - O. Al Hamadi
- Mohammed Bin Rashid Space Centre, Dubai, United Arab Emirates
| | - H. Al Matroushi
- Mohammed Bin Rashid Space Centre, Dubai, United Arab Emirates
| | - Z. Al Shamsi
- Mohammed Bin Rashid Space Centre, Dubai, United Arab Emirates
| | - O. Al Shehhi
- Mohammed Bin Rashid Space Centre, Dubai, United Arab Emirates
| | - M. Chaffin
- Laboratory for Atmospheric and Space Physics, University of Colorado, Boulder, USA
| | - J. Deighan
- Laboratory for Atmospheric and Space Physics, University of Colorado, Boulder, USA
| | - C. Edwards
- Laboratory for Atmospheric and Space Physics, University of Colorado, Boulder, USA
- Northern Arizona University, Flagstaff, AZ USA
| | - N. Ferrington
- Laboratory for Atmospheric and Space Physics, University of Colorado, Boulder, USA
| | - B. Harter
- Laboratory for Atmospheric and Space Physics, University of Colorado, Boulder, USA
| | - G. Holsclaw
- Laboratory for Atmospheric and Space Physics, University of Colorado, Boulder, USA
| | - M. Kelly
- Laboratory for Atmospheric and Space Physics, University of Colorado, Boulder, USA
| | - D. Kubitschek
- Laboratory for Atmospheric and Space Physics, University of Colorado, Boulder, USA
| | - B. Landin
- Laboratory for Atmospheric and Space Physics, University of Colorado, Boulder, USA
| | - R. Lillis
- Space Sciences Lab, University of California, Berkeley, USA
| | - M. Packard
- Laboratory for Atmospheric and Space Physics, University of Colorado, Boulder, USA
| | | | - E. Pilinski
- Laboratory for Atmospheric and Space Physics, University of Colorado, Boulder, USA
| | - B. Pramman
- Laboratory for Atmospheric and Space Physics, University of Colorado, Boulder, USA
| | - H. Reed
- Laboratory for Atmospheric and Space Physics, University of Colorado, Boulder, USA
| | - S. Ryan
- Laboratory for Atmospheric and Space Physics, University of Colorado, Boulder, USA
| | - C. Sanders
- Laboratory for Atmospheric and Space Physics, University of Colorado, Boulder, USA
| | - M. Smith
- NASA Goddard Space Flight Center, Greenbelt, MD USA
| | - C. Tomso
- Laboratory for Atmospheric and Space Physics, University of Colorado, Boulder, USA
| | - R. Wrigley
- Laboratory for Atmospheric and Space Physics, University of Colorado, Boulder, USA
| | - H. Al Mazmi
- UAE Space Agency, Abu Dhabi, United Arab Emirates
| | - N. Al Mheiri
- Mohammed Bin Rashid Space Centre, Dubai, United Arab Emirates
| | - M. Al Shamsi
- Mohammed Bin Rashid Space Centre, Dubai, United Arab Emirates
| | - E. Al Tunaiji
- Mohammed Bin Rashid Space Centre, Dubai, United Arab Emirates
| | - K. Badri
- Mohammed Bin Rashid Space Centre, Dubai, United Arab Emirates
| | | | - S. England
- Virgina Tech University, Blacksburg, VA USA
| | - M. Fillingim
- Space Sciences Lab, University of California, Berkeley, USA
| | - F. Forget
- Laboratoire de Météorologie Dynamique, Paris, France
| | - S. Jain
- Laboratory for Atmospheric and Space Physics, University of Colorado, Boulder, USA
| | - B. M. Jakosky
- Laboratory for Atmospheric and Space Physics, University of Colorado, Boulder, USA
| | - A. Jones
- Laboratory for Atmospheric and Space Physics, University of Colorado, Boulder, USA
| | - F. Lootah
- Mohammed Bin Rashid Space Centre, Dubai, United Arab Emirates
| | - J. G. Luhmann
- Space Sciences Lab, University of California, Berkeley, USA
| | - M. Osterloo
- Space Science International, Boulder, CO USA
| | - M. Wolff
- Space Science International, Boulder, CO USA
| | - M. Yousuf
- Mohammed Bin Rashid Space Centre, Dubai, United Arab Emirates
| |
Collapse
|
19
|
Stuckey K, Dua R, Ma Y, Parker J, Newton PK. Optimal dynamic incentive scheduling for Hawk-Dove evolutionary games. Phys Rev E 2022; 105:014412. [PMID: 35193225 DOI: 10.1103/physreve.105.014412] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2021] [Accepted: 01/05/2022] [Indexed: 06/14/2023]
Abstract
The Hawk-Dove evolutionary game offers a paradigm of the trade-offs associated with aggressive and passive behaviors. When two (or more) populations of players compete, their success or failure is measured by their frequency in the population, and the system is governed by the replicator dynamics. We develop a time-dependent optimal-adaptive control theory for this dynamical system in which the entries of the payoff matrix are dynamically altered to produce control schedules that minimize and maximize the aggressive population through a finite-time cycle. These schedules provide upper and lower bounds on the outcomes for all possible strategies since they represent two extremizers of the cost function. We then adaptively extend the optimal control schedules over multiple cycles to produce absolute maximizers and minimizers for the system.
Collapse
Affiliation(s)
- K Stuckey
- Department of Aerospace & Mechanical Engineering, University of Southern California, Los Angeles, California 90089-1191, USA
| | - R Dua
- Department of Mathematics, University of Southern California, Los Angeles, California 90089-1191, USA
| | - Y Ma
- Department of Physics & Astronomy, University of Southern California, Los Angeles, California 90089-1191, USA
| | - J Parker
- Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California 91125, USA
| | - P K Newton
- Department of Aerospace & Mechanical Engineering, Mathematics, and The Ellison Institute, University of Southern California, Los Angeles, California 90089-1191, USA
| |
Collapse
|
20
|
Parker J, Cornish J, Cripps H, Dober L, Torkington J. The Moondance Bowel Cancer Project schools initiative. Ann R Coll Surg Engl 2021; 103:656-660. [PMID: 34432523 PMCID: PMC10911451 DOI: 10.1308/rcsann.2020.7151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/03/2020] [Indexed: 11/22/2022] Open
Abstract
BACKGROUND The 5-year survival rate for bowel cancer in Wales is poor and lags behind the rest of the UK. The aim of the pilot phase of the Moondance Schools Initiative was to develop, deliver and assess a bowel cancer learning module for secondary school students in South Wales. Ultimately, we aim to introduce this programme into the National Curriculum across Wales. METHODS Two programmes regarding bowel cancer and screening were designed and delivered to a cohort of secondary school pupils in South Wales. This involved interactive teaching with patients and clinicians, practical sessions and live-streamed videos of bowel cancer surgery. Feedback regarding the events and bowel screening was collected from students and their families. RESULTS The programmes were delivered to 185 secondary school students and feedback was extremely positive. The students delivered a live event at the end of the programme to demonstrate their learning to their families and invited guests. Feedback from family members revealed that 100% of respondents were more likely to take a bowel screening test as a result of attending the event. CONCLUSION This project established that a pilot to create young bowel screening ambassadors is feasible and was positively received by students, their families and the local community. Future work will disseminate the programme further and correlate changes in bowel screening participation in the local area as a result of these events.
Collapse
Affiliation(s)
| | - J Cornish
- Cardiff and Vale University Health Board, UK
| | | | | | | | | |
Collapse
|
21
|
Clough A, Hales R, Parker J, McMahon J, Whiteside L, McHugh L, Davies L, Sanders J, Benson R, Nelder C, Choudhury A, Eccles C. PD-0938 impact of an atlas on radiographer inter-observer contour variation in prostate radiotherapy. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07217-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
22
|
Parker J, Gupta S, Torkington J, Dolwani S. O17 Multidisciplinary decision-making strategies may reduce the need for surgery in complex colonic polyps—a systematic review. Br J Surg 2021. [DOI: 10.1093/bjs/znab282.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Abstract
Introduction
The recognition of complex colonic polyps is increasing. Management varies considerably and the impact of this on clinical outcomes is unclear. The aim of this systematic review was to assess the impact of group decision-making strategies and defined selection criteria on the treatment outcomes of complex colonic polyps.
Method
A systematic literature review identified studies reporting complex polyp treatment outcomes and describing their decision-making strategies. Databases searched included PubMed, Web of Science, CINAHL and Scopus. Articles were identified by two blinded reviewers using defined inclusion criteria. The review protocol was registered on PROSPERO and performed in line with PRISMA guidelines.
Results
There were 303 identified articles describing treatment outcomes of complex colonic polyps. Only 9 of these fully described the decision-making strategy and met the inclusion criteria. The median adverse event, unsuspected malignancy and secondary surgery rates were 7.7%, 3.8% and 14.4% respectively. Grouping of articles into a hierarchy of decision-making strategies demonstrated a sequential reduction in secondary surgery rates with improving strategies. The secondary surgery rate was significantly lower in studies using group decision-making and defined selection criteria. There was no significant difference in comparisons of adverse event or unsuspected malignancy rates.
Conclusions
There is limited reporting of decision-making strategies in studies describing complex polyp treatment outcomes. The use of group decision-making and defined selection criteria may reduce the need for surgery in complex colonic polyps. This has implications of cost effectiveness for healthcare systems and benefits to patient quality of life.
Collapse
Affiliation(s)
- J Parker
- Division of Population Medicine, Cardiff University School of Medicine
- Department of Colorectal Surgery, Cardiff and Vale University Health Board
| | - S Gupta
- Division of Population Medicine, Cardiff University School of Medicine
| | - J Torkington
- Department of Colorectal Surgery, Cardiff and Vale University Health Board
| | - S Dolwani
- Division of Population Medicine, Cardiff University School of Medicine
- Department of Colorectal Surgery, Cardiff and Vale University Health Board
| |
Collapse
|
23
|
Pfiffner S, Hallman E, Parker J, Romanski M, Farrar K, Sierzenga N, Dinda S. The Effects of Tert-butyl Hydroquinone (TBHQ) on Estrogen Receptor Alpha (ERα) and Tumor Suppressor Gene p53 in Breast Cancer Cells. J Endocr Soc 2021. [PMCID: PMC8090748 DOI: 10.1210/jendso/bvab048.1009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
Tert-butyl hydroquinone (TBHQ) is an aromatic compound that is commonly used as a preservative in processed food to prevent rancidity and lengthen shelf life. TBHQ is known to act as an antioxidant by protecting cells from radical oxygen species and thus preventing DNA damage. Although previous studies have found TBHQ to cause cancer cell death at high concentrations, they have also contrastingly found TBHQ, when studied in animal models, to enhance carcinogenic effects. However, the effect of TBHQ on breast cancer has not been thoroughly explored. With the prevalence of breast cancer and the wide use of TBHQ in processed food items, it is imperative that we explore their possible relationship. This study examined the effects of TBHQ, alone and in combination with hormones and anti-hormones, on ERα and p53 expression in both MCF-7 and T-47D breast cancer cell lines. To ensure treatment conditions without the presence of endogenous steroids or growth factors, the cells were cultured with a 5% charcoal-stripped fetal bovine serum (FBS) for six days. Western blot analysis revealed alterations in the expression of ERα and p53 protein levels after 24 hours of treatment with varying concentrations of TBHQ (0.005 to 1 mM). A concentration-dependent decrease of ERα protein levels was observed in both cell lines, with a 49% reduction occurring with 100 µM TBHQ as compared to the control. P53 levels portray a continued increase of expression through concentrations of TBHQ (0.005 to 1 mM), found similarly in both cell lines. To gain further insight into possible similarities between BPS and other known effectors of ERα, the optimal concentration of TBHQ (100 μM) was used in combination with hormones and anti-hormones. Down-regulation of ERα protein levels was observed after 24-hour co-treatment of T-47D & MCF-7 cells with a combination of TBHQ and E2. Antiestrogen ICI with TBHQ showed a significant down-regulation as compared to TBHQ alone, and TBHQ with TAM portrayed no significant differences. A similar trend in the effects on p53 expression was depicted in T-47D and MCF-7 cells. Image cytometric analysis with propidium iodide staining was utilized to quantify cell values and viability changes to further portray the effects of TBHQ on T-47D and MCF-7 cellular growth. The viability assay shows a biphasic effect with increasing concentrations of TBHQ, with a maximum decrease in proliferation seen at a concentration of 100 uM TBHQ. TBHQ alone and in combination with E2 and antiestrogens showed a decreased proliferation compared to the control in T-47D cells. However, cytolocalization of ERα upon treatment with estradiol and TBHQ remained unaltered. Our studies offer a unique perspective on the effects of TBHQ on two different breast cancer cell lines, and provide valuable insight for further exploration of the mechanism of action of TBHQ on tumor suppressor gene and steroid receptors.
Collapse
|
24
|
O'Brien J, Fryer S, Parker J, Moore L. The effect of ego depletion on challenge and threat evaluations during a potentially stressful public speaking task. Anxiety Stress Coping 2021; 34:266-278. [PMID: 33141603 DOI: 10.1080/10615806.2020.1839732] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/29/2019] [Revised: 06/05/2020] [Accepted: 08/11/2020] [Indexed: 06/11/2023]
Abstract
It has been well established that challenge and threat evaluations affect the performance of potentially stressful tasks. However, the factors that influence these evaluations have rarely been examined. Objective: This study examined the effects of ego depletion on challenge and threat evaluations during a public speaking task. Method: 262 participants (150 males, 112 females; Mage = 20.5, SD = 4.3) were randomly assigned to either an ego depletion or control group. Participants then completed self-report measures of trait self-control. The ego depletion group performed a written transcription task requiring self-control, while the control group transcribed the text normally. Before the public speaking task, participant's challenge and threat evaluations and subjective ratings of performance were assessed via self-report items. Results: The results of independent t-tests supported the effectiveness of the self-control manipulation. There were no significant differences between the ego depletion and control groups in terms of challenge and threat evaluations or subjective performance. Additional correlation analyses revealed that trait measures of self-control were significantly and negatively related to challenge and threat evaluations and subjective performance. Conclusion: Findings suggest that ego depletion might not influence appraisals of potentially stressful tasks, and thus add to recent evidence questioning the ego-depletion phenomenon.
Collapse
Affiliation(s)
- J O'Brien
- Faculty of Applied Sciences, School of Sport and Exercise, University of Gloucestershire, Gloucester, UK
| | - S Fryer
- Faculty of Applied Sciences, School of Sport and Exercise, University of Gloucestershire, Gloucester, UK
| | - J Parker
- Higher Education Sport, Hartpury University, Gloucester, UK
| | - L Moore
- Department for Health, University of Bath, Bath, UK
| |
Collapse
|
25
|
Li CH, Parker J, Reeve N, Cornish J. P26: EVALUATING AND DEVELOPING A TEACHING TOOL ON FAECAL INCONTINENCE IN THE UNDERGRADUATE MEDICAL CURRICULUM. Br J Surg 2021. [DOI: 10.1093/bjs/znab117.111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Abstract
Introduction
To evaluate the medical school undergraduate curriculum on faecal incontinence (FI) and develop an educational tool to improve the teaching on the subject.
Method
Qualitative analysis of literature research and data collected from medical students via emails, questionnaires and focused group discussions.
Result
FI has not been implanted into the undergraduate curriculum 12,13 and there are variations in teaching on the topic in different medical schools. n= 111 medical students at Cardiff University responded to the survey. FI was reported to be overlooked compared to other types of bowel dysfunction. 38 students reported to have teaching on bowel incontinence, whereas 64 and 74 students had teaching on diarrhoea and constipation respectively. 77% of medical students would like more teaching on bowel incontinence. 9 students participated in a focused group discussion. An interactive e-learning module from Xerte was created based on the students' suggestions and were trialed by a separate cohort of students (n=20). All 20 students showed significant improvement of students' confidence in faecal incontinence (p <= 2.132e∧-6) after completing the e-learning module.
Conclusion
We recommend introducing the educational resource into the undergraduate curriculum of Cardiff University medical school, especially targeting the clinical year, a clear guidance for FI should be published by the relevant postgraduate healthcare faculties and consider assessing at which stage of the postgraduate training should FI be taught.
Take-home message
Baseline knowledge of FI is poor. Lack of content in medical school curriculum and E learning modules potentially useful adjuncts.
Collapse
Affiliation(s)
- CH Li
- University of Cardiff, Medical school
| | - J Parker
- General Surgery, University Hospital of Wales, Cardiff
| | - N Reeve
- General Surgery, University Hospital of Wales, Cardiff
| | - J Cornish
- General Surgery, University Hospital of Wales, Cardiff
| |
Collapse
|
26
|
Parker J, Torkington J, Davies MM, Dolwani S. Laparoscopically assisted endoscopic mucosal resection reduces the need for bowel resection for complex colonic polyps. Br J Surg 2021; 108:e196-e198. [PMID: 33638645 DOI: 10.1093/bjs/znab053] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2021] [Accepted: 01/24/2021] [Indexed: 01/19/2023]
Affiliation(s)
- J Parker
- Division of Population Medicine, Cardiff University School of Medicine, Cardiff, UK.,Department of Colorectal Surgery, Cardiff and Vale University Health Board, Cardiff, UK
| | - J Torkington
- Department of Colorectal Surgery, Cardiff and Vale University Health Board, Cardiff, UK
| | - M M Davies
- Department of Colorectal Surgery, Cardiff and Vale University Health Board, Cardiff, UK
| | - S Dolwani
- Division of Population Medicine, Cardiff University School of Medicine, Cardiff, UK.,Department of Gastroenterology, Cardiff and Vale University Health Board, Cardiff, UK
| |
Collapse
|
27
|
Vlasko-Vlasov VK, Sulwer M, Shevchenko EV, Parker J, Kwok WK. Ring patterns generated by an expanding colloidal meniscus. Phys Rev E 2020; 102:052608. [PMID: 33327138 DOI: 10.1103/physreve.102.052608] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2020] [Accepted: 11/06/2020] [Indexed: 11/07/2022]
Abstract
The drop-and-dry is a common technique allowing for creation of periodic nanoparticle (NP) structures for sensing, photonics, catalysis, etc. However, the reproducibility and scalability of this approach for fabrication of NP-based structures faces serious challenges due to the complexity of the simple, at first glance, evaporation process. In this work we study the effect of the spatial confinement on the NP self-assembly under slow solvent evaporation, when the air-liquid-substrate contact line (CL) expands from the center towards the walls of a cylindrical cell, forming a toroid. Using in situ video monitoring of the stick-slip CL motion, we find regular hydrodynamic perturbations in the meniscus, and reveal fine details of the formation of quasiperiodic rings of close packed NP layers. We report that drying of the toroidal NP droplet has a number of important differences from drying of the classical hemispherical colloidal drops. In toroidal drops we observe linear-in-time average meniscus motion, in contrast to the hemispherical drops where the meniscus moves as a square root of time. While both droplet geometries produce NP ring patterns, the ring width for the toroidal drop decreases with increasing ring radius, while it decreases with decreasing the radius of the hemispherical drop. We suggest that free ligands are the main cause of the Marangoni instabilities driving the periodic vorticity in the meniscus. In addition, we show that the usually ignored contact line tension may yield a considerable contribution to the CL pinning causing the CL slip-stick motion and the ring formation.
Collapse
Affiliation(s)
- V K Vlasko-Vlasov
- Materials Sciences Division, Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - M Sulwer
- Department of Physics, Lewis University, Romeoville, Illinois 60446, USA
| | - E V Shevchenko
- Argonne National Laboratory, Center for Nanoscale Materials, Argonne, Illinois 60439, USA
| | - J Parker
- Department of Physics, Lewis University, Romeoville, Illinois 60446, USA
| | - W K Kwok
- Materials Sciences Division, Argonne National Laboratory, Argonne, Illinois 60439, USA
| |
Collapse
|
28
|
Brown S, Dubec M, Chuter R, Eccles C, Hales R, Parker J, Rodgers J, Whiteside L, Van Herk M, Finn CF, Cobben D. PD-0673: MRI vs CBCT image guidance when treating lymph nodes in patients with locally advanced (LA)-NSCLC. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)00695-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
29
|
Ahmed S, Foulkes L, Leung JT, Griffin C, Sakhardande A, Bennett M, Dunning DL, Griffiths K, Parker J, Kuyken W, Williams JMG, Dalgleish T, Blakemore SJ. Susceptibility to prosocial and antisocial influence in adolescence. J Adolesc 2020; 84:56-68. [PMID: 32858504 PMCID: PMC7674583 DOI: 10.1016/j.adolescence.2020.07.012] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2019] [Revised: 07/17/2020] [Accepted: 07/29/2020] [Indexed: 12/22/2022]
Abstract
Introduction Adolescents are particularly susceptible to social influence and previous studies have shown that this susceptibility decreases with age. The current study used a cross-sectional experimental paradigm to investigate the effect of age and puberty on susceptibility to both prosocial and antisocial influence. Methods Participants (N = 520) aged 11–18 from London and Cambridge (United Kingdom) rated how likely they would be to engage in a prosocial (e.g. “help a classmate with their work”) or antisocial (e.g. “make fun of a classmate”) act. They were then shown the average rating (in fact fictitious) that other adolescents had given to the same question, and were then asked to rate the same behaviour again. Results Both prosocial and antisocial influence decreased linearly with age, with younger adolescents being more socially influenced when other adolescents’ ratings were more prosocial and less antisocial than their own initial rating. Both antisocial and prosocial influence significantly decreased across puberty for boys but not girls (independent of age). Conclusions These findings suggest that social influence declines with increasing maturity across adolescence. However, the exact relationship between social influence and maturity is dependent on the nature of the social influence and gender. Understanding when adolescents are most susceptible to different types of social influence, and how this might influence their social behaviour, has important implications for understanding adolescent social development.
Collapse
Affiliation(s)
- S Ahmed
- Institute of Cognitive Neuroscience, University College London, London, WC1N 3AR, UK.
| | - L Foulkes
- Institute of Cognitive Neuroscience, University College London, London, WC1N 3AR, UK
| | - J T Leung
- Institute of Cognitive Neuroscience, University College London, London, WC1N 3AR, UK
| | - C Griffin
- Institute of Cognitive Neuroscience, University College London, London, WC1N 3AR, UK
| | - A Sakhardande
- Institute of Cognitive Neuroscience, University College London, London, WC1N 3AR, UK
| | - M Bennett
- Medical Research Council Cognition and Brain Sciences Unit, Cambridge University, Cambridge, CB2 7EF, UK
| | - D L Dunning
- Medical Research Council Cognition and Brain Sciences Unit, Cambridge University, Cambridge, CB2 7EF, UK
| | - K Griffiths
- Medical Research Council Cognition and Brain Sciences Unit, Cambridge University, Cambridge, CB2 7EF, UK
| | - J Parker
- Medical Research Council Cognition and Brain Sciences Unit, Cambridge University, Cambridge, CB2 7EF, UK
| | - W Kuyken
- Department of Psychiatry, University of Oxford, Oxford, OX3 7JX, UK
| | - J M G Williams
- Department of Psychiatry, University of Oxford, Oxford, OX3 7JX, UK
| | - T Dalgleish
- Medical Research Council Cognition and Brain Sciences Unit, Cambridge University, Cambridge, CB2 7EF, UK
| | - S J Blakemore
- Institute of Cognitive Neuroscience, University College London, London, WC1N 3AR, UK; Department of Psychology, Downing Street, University of Cambridge, Cambridge, CB2 3EB, UK
| |
Collapse
|
30
|
Mackessy S, Smith C, Saviola A, Schield D, Perry B, Parker J, Castoe T. Complex interactions of biotic and abiotic factors shape venom phenotypes in the Western rattlesnakes. Toxicon 2020. [DOI: 10.1016/j.toxicon.2020.04.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
31
|
Parker J, Liszewski W, Merten AH, Gaddis K, Pragman A, Goldfarb N. A perplexing case of superficial granulomatous pyoderma with sporotrichoid-like distribution. Dermatol Online J 2020; 26:13030/qt5173t7tx. [PMID: 32815693] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2020] [Accepted: 07/29/2020] [Indexed: 06/11/2023] Open
Abstract
Superficial granulomatous pyoderma (SGP) is a rare pyoderma gangrenosum (PG) variant that differs from classic PG in that the ulcers tend to be more superficial, lack a rapidly advancing border, and are not typically associated with an underlying systemic disease. The ulcers are most commonly painless and located on the trunk, with a clean granulating base. They generally do not show undermining but may have a vegetative border. Lesions usually respond well to either topical or intralesional corticosteroids with complete healing. The classic histopathologic finding is a "three-layer granuloma" in the superficial dermis consisting of central neutrophilic inflammation and necrosis, a surrounding layer of histiocytes and multinucleated giant cells, and an outer most layer of plasma cells and eosinophils. Herein, we present a unique case of SGP with sporotrichoid-like distribution on the lower extremity.
Collapse
Affiliation(s)
| | | | | | | | | | - Noah Goldfarb
- Department of Dermatology, University of Minnesota, Minneapolis, MN Department of Dermatology, Minneapolis VA Health Care System, Minneapolis, MN Department of Medicine, University of Minnesota, Minneapolis, MN Department of Medicine, Minneapolis VA Health Care System, Minneapolis, MN.
| |
Collapse
|
32
|
Abstract
AIM In addition to respiratory symptoms, COVID-19 can present with gastrointestinal complaints suggesting possible faeco-oral transmission. The primary aim of this review was to establish the incidence and timing of positive faecal samples for SARS-CoV-2 in patients with COVID-19. METHODS A systematic literature review identified studies describing COVID-19 patients tested for faecal virus. Search terms for MEDLINE included 'clinical', 'faeces', 'gastrointestinal secretions', 'stool', 'COVID-19', 'SARS-CoV-2' and '2019-nCoV'. Additional searches were done in the American Journal of Gastroenterology, Gastroenterology, Gut, Lancet Gastroenterology and Hepatology, the World Health Organization Database, the Centre for Evidence-Based Medicine, New England Journal of Medicine, social media and the National Institute for Health and Care Excellence, bioRxiv and medRxiv preprints. Data were extracted concerning the type of test, number and timing of positive samples, incidence of positive faecal tests after negative nasopharyngeal swabs and evidence of viable faecal virus or faeco-oral transmission of the virus. RESULTS Twenty-six relevant articles were identified. Combining study results demonstrated that 53.9% of those tested for faecal RNA were positive. The duration of faecal viral shedding ranged from 1 to 33 days after a negative nasopharyngeal swab with one result remaining positive 47 days after onset of symptoms. There is insufficient evidence to suggest that COVID-19 is transmitted via faecally shed virus. CONCLUSION There is a high rate of positive polymerase chain reaction tests with persistence of SARS-CoV-2 in faecal samples of patients with COVID-19. Further research is needed to confirm if this virus is viable and the degree of transmission through the faeco-oral route. This may have important implications on isolation, recommended precautions and protective equipment for interventional procedures involving the gastrointestinal tract.
Collapse
Affiliation(s)
- S Gupta
- Division of Population Medicine, Cardiff University School of Medicine, Cardiff, UK
| | - J Parker
- Division of Population Medicine, Cardiff University School of Medicine, Cardiff, UK
| | - S Smits
- Division of Population Medicine, Cardiff University School of Medicine, Cardiff, UK
| | - J Underwood
- Division of Infection and Immunity, Department of Infectious Diseases, Cardiff and Vale University Health Board, Cardiff University, Cardiff, UK
| | - S Dolwani
- Division of Population Medicine, Cardiff University School of Medicine, Cardiff, UK
| |
Collapse
|
33
|
Gupta S, Parker J, Smits S, Underwood J, Dolwani S. Persistent viral shedding of SARS-CoV-2 in faeces - a rapid review. Colorectal Dis 2020; 22:611-620. [PMID: 32418307 PMCID: PMC7276890 DOI: 10.1111/codi.15138] [Citation(s) in RCA: 132] [Impact Index Per Article: 33.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/20/2020] [Revised: 05/02/2020] [Accepted: 05/09/2020] [Indexed: 12/16/2022]
Abstract
AIM In addition to respiratory symptoms, COVID-19 can present with gastrointestinal complaints suggesting possible faeco-oral transmission. The primary aim of this review was to establish the incidence and timing of positive faecal samples for SARS-CoV-2 in patients with COVID-19. METHODS A systematic literature review identified studies describing COVID-19 patients tested for faecal virus. Search terms for MEDLINE included 'clinical', 'faeces', 'gastrointestinal secretions', 'stool', 'COVID-19', 'SARS-CoV-2' and '2019-nCoV'. Additional searches were done in the American Journal of Gastroenterology, Gastroenterology, Gut, Lancet Gastroenterology and Hepatology, the World Health Organization Database, the Centre for Evidence-Based Medicine, New England Journal of Medicine, social media and the National Institute for Health and Care Excellence, bioRxiv and medRxiv preprints. Data were extracted concerning the type of test, number and timing of positive samples, incidence of positive faecal tests after negative nasopharyngeal swabs and evidence of viable faecal virus or faeco-oral transmission of the virus. RESULTS Twenty-six relevant articles were identified. Combining study results demonstrated that 53.9% of those tested for faecal RNA were positive. The duration of faecal viral shedding ranged from 1 to 33 days after a negative nasopharyngeal swab with one result remaining positive 47 days after onset of symptoms. There is insufficient evidence to suggest that COVID-19 is transmitted via faecally shed virus. CONCLUSION There is a high rate of positive polymerase chain reaction tests with persistence of SARS-CoV-2 in faecal samples of patients with COVID-19. Further research is needed to confirm if this virus is viable and the degree of transmission through the faeco-oral route. This may have important implications on isolation, recommended precautions and protective equipment for interventional procedures involving the gastrointestinal tract.
Collapse
Affiliation(s)
- S. Gupta
- Division of Population MedicineCardiff University School of MedicineCardiffUK
| | - J. Parker
- Division of Population MedicineCardiff University School of MedicineCardiffUK
| | - S. Smits
- Division of Population MedicineCardiff University School of MedicineCardiffUK
| | - J. Underwood
- Division of Infection and ImmunityDepartment of Infectious DiseasesCardiff and Vale University Health BoardCardiff UniversityCardiffUK
| | - S. Dolwani
- Division of Population MedicineCardiff University School of MedicineCardiffUK
| |
Collapse
|
34
|
Parker J, Morse M, Benard P, Pfiffner S, Romanski M, Dinda S. SAT-728 The Regulation of Tumor Suppressor Genes P53, BRCA-2, and Cell Cycle Protein p21 by Bisphenol S (BPS) in MCF-7 and T47-D Breast Cancer Cells. J Endocr Soc 2020. [PMCID: PMC7207750 DOI: 10.1210/jendso/bvaa046.1341] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
Bisphenol A (BPA) is considered to be an endocrine disrupting chemical (EDC), which mimics endogenous hormones and is linked to various cancers. Bisphenol S (BPS) is a BPA analogue, often used in plastics. BPS can leach into food and drink products, exposing humans to these chemicals. Evidence suggests BPS is also an EDC with similar endocrine disrupting effects. Despite hopes for a safer alternative, research has shown BPS possesses estrogenic activity due to its structural similarities with its analogue BPA. Previously we have shown the effects of BPS on estrogen receptor-alpha (ERα) and BRCA-1 in both MCF-7 and T-47D breast cancer cells. The wild-type p53 and BRCA-2 work to prevent cancer by monitoring and repairing DNA damage; however, in breast cancer patients these genes are often mutated. Mutated p53 will induce the cell cycle protein p21 to act as an oncogenic transcription factor. In the present study, we have examined the effects of BPS, alone and in combination with hormones and anti-hormones, on p53, BRCA-2, and p21 in both MCF-7 and T-47D cell lines by utilizing western blot analyses, cellular viability assays, confocal microscopy, apoptosis assay, and RT-qPCR analyses. Western blot studies revealed alterations in the expression of p53, BRCA-2, and p21 related with varying concentrations of BPS (4-20 µM). In comparison to the control, p53 expression increased (65-95%) in the presence of BPS in both MCF-7 and T-47D cells. In addition, BRCA-2 expression revealed a similar increase in both cell lines when treated with BPS. However, p21 expression decreased (approximately 50%) with increasing concentrations in both cell lines. For further evaluation, an optimal concentration of 8 µM BPS was then used in combination with various hormones and anti-hormones. Compared to the control, BPS and E2 were up regulated in a similar fashion to p53. A similar trend in the effects on BRCA-2 expression was depicted in T-47D and MCF-7 cells. However, in p21, BPS and E2 were down regulated in both MCF-7 and T-47D breast cancer cells. In order to determine the influence of BPS on the growth of breast cancer cells, image cytometric analysis with propidium iodide staining was utilized to quantify alterations in T-47D and MCF-7 cell numbers and viability. Upon treatment of BPS concentrations (4-20 µM), an increase in cellular proliferation (12-60% increase) occurred in both cell lines. These cellular proliferative effects of BPS and E2 were sensitive to combination treatments with anti-estrogens. Confocal microscopy was utilized to examine the cytolocalization of p53 upon exposure to BPS alone and in combination with hormones and anti-hormones. The results from this study will yield a greater understanding of the molecular regulation of BPS action via the p53, BRCA-2, and p21 signaling pathways linked with breast cancer.
Collapse
Affiliation(s)
| | - Mia Morse
- OAKLAND UNIVERSITY, Rochester, MI, USA
| | | | | | | | | |
Collapse
|
35
|
Parker J, Neill B, Whitsitt J, Rajpara A, Aires D. Exacerbation of Pediatric Periorificial Dermatitis: A Novel Adverse Reaction. J Drugs Dermatol 2020; 19:428. [PMID: 32401455] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
|
36
|
Parker J, Liszewski W, Merten AH, Gaddis K, Pragman A, Goldfarb N. A perplexing case of superficial granulomatous pyoderma with sporotrichoid-like distribution. Dermatol Online J 2020. [DOI: 10.5070/d3266049322] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
|
37
|
Troxel W, D'Amico E, Dickerson D, Brown R, Klein D, Parker J, Woodward M, Johnson C. Psychosocial and cultural influences on sleep health in urban American Indian/ Alaskan native adolescents: preliminary results from the nayshaw study. Sleep Med 2019. [DOI: 10.1016/j.sleep.2019.11.1090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
38
|
Schmidt JW, Vikram A, Thomas K, Arthur TM, Weinroth M, Parker J, Hanes A, Geornaras I, Morley PS, Wheeler TL, Belk KE. Antimicrobial Resistance in Retail Ground Beef with and Without a “Raised Without Antibiotics” Claim. Meat and Muscle Biology 2019. [DOI: 10.22175/mmb.10781] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
ObjectivesThe occurrences of human bacterial infections complicated by antimicrobial resistance (AMR) have increased in recent decades. Concerns have been raised that food-animal production practices that incorporate antimicrobials contribute significantly to human AMR exposures since food-animal production accounts for approximately 81% of U.S. antimicrobial consumption by mass. Although empirical studies comparing AMR levels in meat products, including ground beef, are scant ground beef products with Raised without Antibiotics (RWA) label claims are perceived to harbor less AMR than “conventional” (CONV) products with no label claims regarding antimicrobial use. The objective of this research was to determine AMR levels in retail ground beef with and without an RWA label claims.Materials and MethodsRetail ground beef samples were obtained from 6 U.S. cities. Samples were obtained on the following dates: 9/18/2017, 10/30/2017, 11/27/2017. 1/29/2018. 3/5/2018, and 6/11/2018. A total of 599 samples were obtained. Samples with a “Raised without Antibiotics” or USDA Organic claim (N = 299) were assigned to the RWA production system. Samples lacking a “Raised without Antibiotics” claim (N = 300) were assigned to the CONV production system. Each sample was cultured for the detection of five antimicrobial resistant bacteria (ARB). Genomic DNA was isolated from each sample and qPCR was used to determine the abundance of ten antimicrobial resistance genes (ARGs). The impacts of production system and city on ARB detection were assessed by the Likelihood-ratio chi-squared test. The impacts of production system and city on ARG abundance was assessed by two-way ANOVA.ResultsTetracycline-resistant Escherichia coli (CONV = 46.3%; RWA = 34.4%) and erythromycin-resistant Enterococcus (CONV = 48.0%; RWA = 37.5%) were more frequently (P < 0.01) detected in CONV. Detection of third generation cephalosporin-resistant E. coli (CONV = 5.7%; RWA = 1.0%), vancomycin-resistant Enterococcus (CONV = 0.0%; RWA = 0.0%) and methicillin-resistant Staphylococcus aureus (CONV = 1.3%; RWA = 0.7%) did not differ (P = 1.00). The blaCTX-M ARG was more abundant in CONV (2.4 vs. 2.1 log copies/gram, P = 0.01) but the tet(A) (2.4 vs. 2.5 log copies/gram, P = 0.02) and tet(M) (3.6 vs. 3.9 log copies/gram, P < 0.01) ARGs were more abundant in RWA. aadA1, blaCMY-2, mecA, erm(B), and tet(B) abundances did not differ significantly (Fig. 5) (P > 0.05). Abundances of aac (6’)-Ie-aph (2”)-Ia and blaKPC-2 were not analyzed since they were quantified in less than 5% of the samples.ConclusionU.S. retail CONV and RWA ground beef harbor generally similar levels of AMR since only 5 of 15 AMR measurements were statistically different between production systems. Three AMR measurements were higher in CONV, while 2 AMR measurements were higher in RWA. These results are in general agreement with a recently published study authored by our group that examined antimicrobial resistance in CONV and RWA ground beef obtained from U.S. foodservice suppliers (Vikram et al., J. Food Prot. 81:2007–2018. 2018.). Together these studies suggest that antimicrobial use during U.S. cattle production has minimal to no impact on human exposure to AMR via ground beef.Figure 5.
Collapse
Affiliation(s)
- J. W. Schmidt
- USDA, Agricultural Research Service U.S. Meat Animal Research Center
| | - A. Vikram
- USDA, Agricultural Research Service U.S. Meat Animal Research Center
| | - K. Thomas
- Colorado State University Animal Sciences
| | - T. M. Arthur
- USDA, Agricultural Research Service U.S. Meat Animal Research Center
| | | | - J. Parker
- Colorado State University Clinical Sciences
| | - A. Hanes
- Colorado State University Clinical Sciences
| | | | - P. S. Morley
- Texas A&M University College of Veterinary Medicine
| | - T. L. Wheeler
- USDA, Agricultural Research Service U.S. Meat Animal Research Center
| | - K. E. Belk
- Colorado State University Animal Sciences
| |
Collapse
|
39
|
Browne E, Pace B, Margolis D, Strahl B, Dronamraju R, Jefferys S, Parker J. Epigenomic characterisation of a primary cell model of HIV latency. J Virus Erad 2019. [DOI: 10.1016/s2055-6640(20)30097-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
40
|
Lloyd V, Morse M, Purakal B, Parker J, Benard P, Crone M, Pfiffner S, Szmyd M, Dinda S. Hormone-Like Effects of Bisphenol A on p53 and Estrogen Receptor Alpha in Breast Cancer Cells. Biores Open Access 2019; 8:169-184. [PMID: 31681507 PMCID: PMC6823605 DOI: 10.1089/biores.2018.0048] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023] Open
Abstract
Bisphenol A (BPA) is a polymerizing agent commonly found in plastics that has been linked to xenoestrogenic activity. In this study, we analyzed the estrogen-like effects of BPA on the expression of estrogen receptor (ER)α and p53 with hormonal and antihormonal treatments in T-47D and MCF-7 cells. Cells were cultured in medium containing 5% charcoal-stripped fetal bovine serum for 6 days to deplete any endogenous steroids or effectors. The cells were then treated for 24 h with 600 nM BPA, which was determined to be the optimal value by a concentration study of BPA from 1 nM to 2 μM. Extracted cellular proteins were quantified and subjected to sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE)/Western blot analysis. The cell proliferation assays were quantified upon exposure to BPA. Laser confocal microscopy was performed to determine the cytolocalization of p53 and ERα upon treatment with BPA. Western blot analysis revealed that BPA caused an increase in the cellular protein p53 in a concentration-dependent manner. While treatment with BPA did not affect the cytolocalization of p53, an increase in cell proliferation was observed. Our studies provide interesting leads to delineate the possible mechanistic relationship among BPA, ER, and tumor suppressor proteins in breast cancer cells.
Collapse
Affiliation(s)
- Victoria Lloyd
- Department of Biomedical Diagnostic and Therapeutic Sciences, School of Health Sciences, Center of Biomedical Research, Oakland University, Rochester, Michigan
| | - Mia Morse
- Department of Biomedical Diagnostic and Therapeutic Sciences, School of Health Sciences, Center of Biomedical Research, Oakland University, Rochester, Michigan
| | - Betsy Purakal
- Department of Biomedical Diagnostic and Therapeutic Sciences, School of Health Sciences, Center of Biomedical Research, Oakland University, Rochester, Michigan
| | - Jordan Parker
- Department of Biomedical Diagnostic and Therapeutic Sciences, School of Health Sciences, Center of Biomedical Research, Oakland University, Rochester, Michigan
| | - Paige Benard
- Department of Biomedical Diagnostic and Therapeutic Sciences, School of Health Sciences, Center of Biomedical Research, Oakland University, Rochester, Michigan
| | - Michael Crone
- Department of Biomedical Diagnostic and Therapeutic Sciences, School of Health Sciences, Center of Biomedical Research, Oakland University, Rochester, Michigan
| | - Samantha Pfiffner
- Department of Biomedical Diagnostic and Therapeutic Sciences, School of Health Sciences, Center of Biomedical Research, Oakland University, Rochester, Michigan
| | - Monica Szmyd
- Department of Biomedical Diagnostic and Therapeutic Sciences, School of Health Sciences, Center of Biomedical Research, Oakland University, Rochester, Michigan
| | - Sumi Dinda
- Department of Biomedical Diagnostic and Therapeutic Sciences, School of Health Sciences, Center of Biomedical Research, Oakland University, Rochester, Michigan
| |
Collapse
|
41
|
Roberts PS, Aronow HU, Parker J, Riggs RV. Measuring Frailty in Inpatient Rehabilitation. PM R 2019; 12:356-362. [PMID: 31622049 DOI: 10.1002/pmrj.12263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2019] [Accepted: 10/07/2019] [Indexed: 11/05/2022]
Abstract
BACKGROUND In response to the global aging population, there has been increasing research on frailty. How frailty is conceptualized is shifting with the development of frailty models, especially in the acute care arena. OBJECTIVE To explore frailty/vulnerability risk factors available at admission that were associated with salient patient outcomes within the context of inpatient rehabilitation. DESIGN Methodologies in acute care are not easily adapted for a typical admission evaluation or a rehabilitation patient. In this study, the concept of frailty among patients admitted to rehabilitation was developed from risk factors available at admission that were associated with two patient outcomes, adverse hospital outcomes and 30-day hospital readmissions. SETTING Inpatient rehabilitation. PATIENTS Data were included on all patients (n = 768) discharged from an inpatient rehabilitation unit of an academic medical center from 1 January 2012 through 31 December 2012. INTERVENTIONS Not applicable. MAIN OUTCOME MEASURE Adverse events within the inpatient rehabilitation stay and 30-day hospital readmissions. RESULTS Significant independent factors associated with adverse events in the rehabilitation unit included African American (1.77 OR; 95% CI 1.06-2.96), Hispanic (3.17 OR; 95% CI 1.13-8.94), having >9 total comorbid conditions (1.44 OR; 95% CI 1.244-1.66), and sphincter control domain (including bladder and bowel management) ≤ 9 FIM (0.92 OR; 95% CI 0.86-0.98). For 30-day readmission three variables were found to be significant: onset ≥7 days (2.31 OR; 95% CI 1.28-4.22), requiring a tube for feeding (3.45 OR; 95% CI 1.433-11.12), and being obese (4.72 OR; 95% CI 1.433-15.58). CONCLUSIONS The findings highlight the need for early admission screening and identification of risk factors which can provide the time in the rehabilitation setting for the clinical team to treat and prevent the potential for poor outcomes.
Collapse
Affiliation(s)
- Pamela S Roberts
- Department of Physical Medicine and Rehabilitation, Cedars-Sinai, Los Angeles, CA.,Department of Enterprise Information Services, Cedars-Sinai, Los Angeles, CA
| | - Harriet U Aronow
- Department of Nursing Research and Performance Improvement, Cedars-Sinai, Los Angeles, CA
| | - Jordan Parker
- Department of Physical Medicine and Rehabilitation, Cedars-Sinai, Los Angeles, CA
| | - Richard V Riggs
- Department of Physical Medicine and Rehabilitation, Cedars-Sinai, Los Angeles, CA.,Department of Enterprise Information Services, Cedars-Sinai, Los Angeles, CA
| |
Collapse
|
42
|
Anand I, Konstam M, Udelson J, Butler J, Klein H, Parker J, Teerlink J, Libbus I, Amurthur B, Kenknight B, Ardell J, Gregory D, Massaro J, Dicarlo L. P3522Vagus nerve stimulation for chronic heart failure: differences in therapy delivery and clinical efficacy in ANTHEM-HF, INOVATE-HF, and NECTAR-HF. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0386] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Background
Vagus Nerve Stimulation (VNS) is meant to deliver Autonomic Regulation Therapy (ART) to neurological targets with sufficient neuromodulation (NM) to ameliorate chronic heart failure (CHF). VNS delivery consists of its intensity (a combination of pulse amplitude, pulse frequency, and pulse duration), polarity, duty cycle (DC; stimulation “on” time and “off” time), and mode (continuous, or intermittent and periodic). In the ANTHEM-HF Pilot Study patients with CHF and reduced ejection fraction (HFrEF), VNS intensity was up-titrated until a change in heart rate (HR) dynamics was objectively confirmed. This did not require any change in GDMT and was associated with significant improvements in LVEF, 6-minute walk distance (6MWD), Minnesota Living with HF (MLWHF) score, and HR variability.
Methods
Qualitative and quantitative analyses used data from peer-reviewed publications and other sources in the public domain to compare VNS delivery in ANTHEM-HF, INOVATE-HF, and NECTAR-HF.
Results (Table): Up-titration of VNS intensity was attempted in all 3 studies. In contrast to ANTHEM-HF, INOVATE-HF aimed only at peripheral neural targets. VNS intensity was delivered at a lower pulse frequency, and had a variable DC as a consequence of R-wave synchronization and only intermittent, periodic stimulation. In NECTAR-HF VNS intensity was delivered at a higher pulse frequency, and this was associated with intolerable adverse off-target effects which restricted VNS up-titration. Significant improvements in EF, 6MWD, MLWHF, and SDNN occurred in ANTHEM-HF relative to the other studies.
ANTHEM-HF (n=60) INOVATE-HF (n=436) NECTAR-HF (n=63) Neural Target Central/Peripheral Peripheral Central/Peripheral Delivery Site Left or right CVN Right CVN Right CVN Delivery Intensity: Amplitude (milliamperes) 2.0±0.6 3.9±1.0 1.4±0.8 Frequency (Hertz) 10 1–2 20 Duration (microseconds) 250 500 300 Electrode Polarity (Cathode) Caudal Cephalad Caudal Duty Cycle 23% 25% 17% On Time/Off Time (seconds) 18/62 Variable 10/50 Mode of Delivery Cyclic/Continuous Intermittent/Periodic Cyclic/Continuous Clinical Efficacy at 6 Months: EF 32.4±7.2 to 37.2±10.4 Not available 30.5±6.0 to 32.7±6.4 6MWD 287±66 to 346±78 317±109 to 347±123 Not available MLWHFS 40±14 to 21±10 Not available 44.2±22.2 to 35.8±20.8 SDNN 94±26 to 111±50 Not available 146±48 to 130±52 Values reported as mean ± standard deviation; CVN = Cervical vagus nerve. *p<0.05 versus NECTAR-HF; **p<0.05 versus INOVATE-HF; ***p<0.025 versus NECTAR-HF; ****p<0.001 versus NECTAR-HF (Analysis using two-sample t-test of the means).
Conclusion
VNS differed in ANTHEM-HF when compared to INOVATE-HF and NECTAR-HF. The neural targets, pulse frequencies for titration, and the DC for NM were different. VNS in ANTHEM-HF was clinically efficacious. The ongoing ANTHEM-HFrEF Pivotal Study uses a similar paradigm.
Acknowledgement/Funding
LivaNova PLC
Collapse
Affiliation(s)
- I Anand
- University of Minnesota, Minneapolis, United States of America
| | - M Konstam
- Tufts Medical Center, CardioVascular Center, Boston, United States of America
| | - J Udelson
- Tufts Medical Center, CardioVascular Center, Boston, United States of America
| | - J Butler
- The University of Mississippi Medical Center, Department of Medicine, Jackson, United States of America
| | - H Klein
- University of Rochester, Department of Medicine, Rochester, United States of America
| | - J Parker
- University of Toronto, University Health Network, Toronto, Canada
| | - J Teerlink
- University of California San Francisco, San Francisco, United States of America
| | - I Libbus
- LivaNova USA, Inc., Houston, United States of America
| | - B Amurthur
- LivaNova USA, Inc., Houston, United States of America
| | - B Kenknight
- LivaNova USA, Inc., Houston, United States of America
| | - J Ardell
- University of California Los Angeles, Neurocardiology Center, Los Angeles, United States of America
| | - D Gregory
- Clinical Cardiovascular Science Foundation, Boston, United States of America
| | - J Massaro
- Boston University, Boston, United States of America
| | - L Dicarlo
- LivaNova USA, Inc., Houston, United States of America
| |
Collapse
|
43
|
He J, Zhou K, Parker J. THE EFFECT OF VITAMIN C ON THE VASODILATOR RESPONSE TO NITROGLYCERIN IN THOSE WITH AND WITHOUT ALDEHYDE DEHYDROGENASE-2 POLYMORPHISM. Can J Cardiol 2019. [DOI: 10.1016/j.cjca.2019.07.621] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
44
|
Jaworski L, Griffith K, Mancini B, Jolly S, Boike T, Moran J, Dominello M, Wilson M, Parker J, Burmeister J, Gardner S, Fraser C, Miller L, Baldwin K, Mietzel M, Grubb M, Kendrick D, Pierce L, Spratt D, Hayman J. Contemporary Practice Patterns for Radiotherapy of Bone Metastases: Preliminary Analysis of Prospective Data from a Statewide Consortium Focusing on Extended Fractionation. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.162] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
45
|
Crone M, Lloyd V, Szmyd M, Morse M, Badamo B, Parker J, Paige B, Thomas M, Dinda S. MON-038 The Effects of Isoliquiritigenin (ISL) on the Expression of Estrogen Receptor and Tumor Suppressor Genes BRCA-1 and P53 in Breast Cancer Cells. J Endocr Soc 2019. [PMCID: PMC6551116 DOI: 10.1210/js.2019-mon-038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
Naturally sourced treatments are increasingly sought for health issues including breast cancer. Isoliquiritigenin (ISL), a phenolic flavonoid in licorice root, has recently received attention in public and scientific communities for its antioxidant, anti-inflammatory and tumor suppressive effects. Standard medical practice now includes determining receptor status of breast cancers and estimates show that 55-65% of women with a BRCA1 gene mutation will develop hereditary breast cancer, therefore finding treatment options for receptor-positive patients is critically important. This study examined the effects of ISL, alone and in combination with hormones and anti-hormones, on ERα, p53, and BRCA1 expression in MCF-7 and T-47D breast cancer cells by utilizing western blot analyses, cellular viability assays, confocal microscopy, apoptosis assay and RT-qPCR analyses. To ensure treatment conditions without the presence of endogenous steroids or growth factors, cells were cultured in a medium containing 5% charcoal-stripped fetal bovine serum (FBS) for a duration of 6 days. For western blot analyses, cells were treated with various concentrations of ISL ranging from 5-100 µM for 24 hours. Compared to the control, a concentration dependent decrease of ERα (85%) and BRCA1 (60%) was noted in both cell lines, while the expression of p53 seemed to be altered based on the specific breast cancer cell lines. In our hormone studies, we used the optimal concentration of 50μM ISL alone and in combination with hormones and anti-hormones. After 24-hour treatment of ISL, E2, and E2 with ISL on the breast cancer, cells showed a decrease in ERα and BRCA-1 expression compared to the control. Combination treatment of ISL with anti-hormone ICI revealed a significant down regulation (approximately 65-85%) of ERα, BRCA-1, and p53 in T-47D cells. The same treatment conditions in MCF-7 cells revealed a significant down regulation of ERα and BRCA-1, while p53 expression was up regulated. Image cytometric analysis with propidium iodide staining was performed to examine the effects that ISL has on cellular viability in T-47D and MCF-7 cells. Cells treated for 6 days with 50 μM ISL concentration with hormone and anti-hormones displayed a decrease in cell proliferation compared to the control in both cell lines. RT-qPCR studies revealed a transcriptional expression of ESR1 and BRCA-1 mRNA levels that correlate with the translational data obtained via western blot analyses. Cytolocalization studies are in progress and apoptosis assays are currently being performed to determine the mechanism(s) of cell death. Our studies offer an intriguing direction to explore the molecular mechanisms of ISL on the steroid receptors and tumor suppressor gene in breast cancer cells.
Collapse
Affiliation(s)
| | | | - Monica Szmyd
- Oakland University William Beaumont School of Medicine, Rochester, MI, United States
| | - Mia Morse
- Oakland University, Rochester, MI, United States
| | | | | | - Benard Paige
- Oakland University, Rochester, MI, United States
| | | | - Sumi Dinda
- School of Health Sciences, Oakland University, Rochester, MI, United States
| |
Collapse
|
46
|
Loeb A, Shah B, Baumgarten A, Parker J, Carrion R. 043 The “Carrion Cast”: Intracorporal Antimicrobial Cast Using Synthetic High Purity CaSO4 for the Treatment of Infected Penile Implant – “Updated” Surgeon Protocol. J Sex Med 2019. [DOI: 10.1016/j.jsxm.2019.01.054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
47
|
Nealon S, Baumgarten A, Carrion R, Parker J. 297 The Use of Antibiotic Impregnated Beads in Setting of Penile Implant Infection: A Single Institution Experience. J Sex Med 2019. [DOI: 10.1016/j.jsxm.2019.01.299] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
48
|
Turnbull AK, Martinez-Perez C, Mok S, Tanioka M, Fernando A, Renshaw L, Keys J, Wheless A, Garrett A, Parker J, He X, Sims AH, Carey LA, Perou CM, Dixon JM. Abstract P5-04-27: Investigating the incidence of ESR1 gene amplification in breast cancers resistant to multiple endocrine agents. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p5-04-27] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Around 70% of all breast cancers (BCs) are estrogen receptor positive (ER+), but some do not respond to endocrine therapy (ET) and many eventually develop resistance. ESR amplification (ESRA) linked to an increase in ESR1 gene expression is known to occur in some cancers that are endocrine resistant. However, the incidence of ESRA has been the object of debate and its clinical significance remains unclear. This study aimed to investigate the incidence of ESRA in BCs resistant to multiple sequential ETs and optimise a fluorescence in-situ hybridisation (FISH) methodology to robustly detect ESRA.
Methods: Two unique cohorts have been studied:
(A) 20 post-menopausal women with ER+ BC with acquired resistance to letrozole, subsequently treated with up to 4 different lines of ET. Serial RNA and DNA from 3-5 cancer samples per patient (58 samples from 20 patients) were analysed by Ribo0-RNAseq and DNA exome sequencing;
(B) 18 post-menopausal women who developed ER+ BC recurrences on 1st line adjuvant letrozole, then on 2nd line tamoxifen and subsequently on 3rd line exemestane. Tissues were collected at the time of each surgery.
We have optimised a FISH method to assess ESRA in these tissues.
Results: In cohort A, 6/20 patients developed ESR1 gene amplification (ESRA) at some point during treatment. In 5 of these cases, ESRA was only found while on 2nd or 3rd line exemestane but was not present on acquired resistance to previous letrozole or tamoxifen. 1 patient had ESRA at the time of first recurrence on letrozole.
The FISH method showed concordance with the genomic analysis. This suggests that ESRA may be associated with BCs that are treated with and then become resistant to exemestane.
ESRA is also evident in samples from Cohort B, which includes 18 exemestane resistant cases. The complete analysis is ongoing.
Conclusions:
· ESRA can be seen in ER+ recurrent BCs.
· ESRA may be associated with BCs treated with 2nd or 3rd line exemestane.
· The frequency of ESRA in endocrine and exemestane resistance can now be ascertained using an optimised FISH-based method, which is more cost-effective than alternative genomic and biochemical methods.
Citation Format: Turnbull AK, Martinez-Perez C, Mok S, Tanioka M, Fernando A, Renshaw L, Keys J, Wheless A, Garrett A, Parker J, He X, Sims AH, Carey LA, Perou CM, Dixon JM. Investigating the incidence of ESR1 gene amplification in breast cancers resistant to multiple endocrine agents [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P5-04-27.
Collapse
Affiliation(s)
- AK Turnbull
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Arab Emirates; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - C Martinez-Perez
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Arab Emirates; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - S Mok
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Arab Emirates; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - M Tanioka
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Arab Emirates; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - A Fernando
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Arab Emirates; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - L Renshaw
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Arab Emirates; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - J Keys
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Arab Emirates; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - A Wheless
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Arab Emirates; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - A Garrett
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Arab Emirates; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - J Parker
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Arab Emirates; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - X He
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Arab Emirates; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - AH Sims
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Arab Emirates; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - LA Carey
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Arab Emirates; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - CM Perou
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Arab Emirates; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - JM Dixon
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Arab Emirates; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| |
Collapse
|
49
|
Martinez-Perez C, Turnbull AK, Tanioka M, Fernando A, Renshaw L, Keys J, Wheless A, Garrett A, Parker J, He X, Sims AH, Carey LA, Perou CM, Dixon JM. Abstract P5-04-14: Tracking ESR1 mutation clonal evolution in breast cancer using in situ mutation detection. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p5-04-14] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Approximately 70% of breast cancers (BCs) are estrogen receptor positive (ER+). Not all ER+ cancers respond to endocrine therapy (ET) and many eventually develop acquired resistance. Next-generation sequencing (NGS) has shown ESR1 mutations (ESRMs) are present in 10-50% of recurrent/metastatic cancers treated with aromatase inhibitors (AIs). Many of these mutations are located in the ligand-binding domain of ER, so they can lead to constitutive activation. This suggests ESRMs are a major mechanism of acquired resistance to endocrine therapy (ET) and numerous studies have shown a link between ESRMs and reduced sensitivity to 2nd line ET. The aim of this project was to investigate the incidence and clonal evolution of common ESRMs in BCs resistant to multiple sequential ETs using NGS, as well as novel PCR and in situ mutation detection methods.
Methods: We have optimised an allele-specific real-time PCR (rtPCR) assay and an in situ mutation detection method (ER-ISMD) for the assessment of ESRMs. Both have been designed to identify a missense gain-of-function D538G mutation with a single nucleotide-resolution in formalin-fixed paraffin-embedded (FFPE) BC tissues.
Two unique cohorts have been studied:
(A) 20 post-menopausal women (PMW) with ER+ BC who acquired resistance to letrozole and were treated with up to 4 subsequent lines of ET. Serial RNA and DNA from 3-5 cancer samples per patient (58 samples from 20 patients) were analysed by Ribo0-RNAseq, DNA exome sequencing, rtPCR and ER-ISMD.
(B) 150 PMW with ER+ BC who developed local (n=79), lymph node (n=59) or distant (n=12) recurrences on 1st line adjuvant letrozole, anastrozole or tamoxifen. Of these, 48 patients developed subsequent recurrences on 2nd line ET. Tissue samples from each recurrence and matched primary BC were collected.
Results: In cohort A, 5/20 patients (20%) had expansion of a D538G ESR1 mutation clone at time of resistance 1st line ET (3:letrozole, 1:anastrozole, 1:tamoxifen). The mutant allele frequency (MAF) increased further in the 4 BCs treated with 2nd line ET (2:tamoxifen, 2:exemestane) and further still in the 1 BC who received 3rd line exemestane. 0/6 patients with ESRM responded to subsequent ET. Allele-specific rtPCR and ER-ISMD have been used to validate these findings and also identified low frequency ESRM clones in the sequential samples prior to the development of clinical resistance, that were not reported by NGS. Both methods have also been applied to screen tissues from patients in cohort B, where ESRMs have also been identified in recurrent samples. Complete analysis is currently ongoing.
Conclusions:
· ESRMs develop and expand in some BCs as a mechanism for acquired resistance to ET and are associated with a lack of response to subsequent standard ETs.
· Allele-specific rtPCR can detect ESRMs and is more cost-effective and easier to use than NGS for ER mutation analysis.
· Some ESRMs predate clinical resistance.
· ER-ISMD is a novel approach that allows for identification and visualisation of the distribution of mutant clones in morphologically intact FFPE tissue.
· ER-ISMD has the potential to become a clinically useful tool to help direct the use of 2nd line ET in routine care.
Citation Format: Martinez-Perez C, Turnbull AK, Tanioka M, Fernando A, Renshaw L, Keys J, Wheless A, Garrett A, Parker J, He X, Sims AH, Carey LA, Perou CM, Dixon JM. Tracking ESR1 mutation clonal evolution in breast cancer using in situ mutation detection [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P5-04-14.
Collapse
Affiliation(s)
- C Martinez-Perez
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - AK Turnbull
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - M Tanioka
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - A Fernando
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - L Renshaw
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - J Keys
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - A Wheless
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - A Garrett
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - J Parker
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - X He
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - AH Sims
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - LA Carey
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - CM Perou
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| | - JM Dixon
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom
| |
Collapse
|
50
|
Hardeman A, Grushko T, Clayton W, Hurley I, Khramtsova G, Parker J, Perou C, Olopade O. Abstract P3-07-05: Not presented. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p3-07-05] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
This abstract was not presented at the conference.
Citation Format: Hardeman A, Grushko T, Clayton W, Hurley I, Khramtsova G, Parker J, Perou C, Olopade O. Not presented [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P3-07-05.
Collapse
Affiliation(s)
- A Hardeman
- University of Chicago Medical Center, Chicago, IL; University of North Carolina Chapel Hill, Chapel Hill, NC
| | - T Grushko
- University of Chicago Medical Center, Chicago, IL; University of North Carolina Chapel Hill, Chapel Hill, NC
| | - W Clayton
- University of Chicago Medical Center, Chicago, IL; University of North Carolina Chapel Hill, Chapel Hill, NC
| | - I Hurley
- University of Chicago Medical Center, Chicago, IL; University of North Carolina Chapel Hill, Chapel Hill, NC
| | - G Khramtsova
- University of Chicago Medical Center, Chicago, IL; University of North Carolina Chapel Hill, Chapel Hill, NC
| | - J Parker
- University of Chicago Medical Center, Chicago, IL; University of North Carolina Chapel Hill, Chapel Hill, NC
| | - C Perou
- University of Chicago Medical Center, Chicago, IL; University of North Carolina Chapel Hill, Chapel Hill, NC
| | - O Olopade
- University of Chicago Medical Center, Chicago, IL; University of North Carolina Chapel Hill, Chapel Hill, NC
| |
Collapse
|